A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Clinical trial NCT01485172 · COMPLETED

Trial details

NCT number: NCT01485172
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2012-01-31
Primary completion: 2014-04-30
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.